Vitamin D Oral Replacement in Asthma

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

January 30, 2019

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
AsthmaVitamin D DeficiencyPediatric Obesity
Interventions
DIETARY_SUPPLEMENT

Vitamin D3 oral regimen

Vitamin D3 oral regimens supplementation

Trial Locations (15)

19803

Nemours/Alfred I duPont Hospital for Children, Wilmington

26506

West Virginia University, Morgantown

29208

University of South Carolina, Columbia

39216

University of Mississippi Medical Center, Jackson

40292

University of Louisville, Louisville

59804

Community Medical Center, Missoula

64108

Children's Mercy Hospital, Kansas City

68198

University of Nebraska Medical Center/Children's Hospital and Medical Center, Omaha

70808

Pennington Biomedical Research Center, Baton Rouge

72202

Arkansas Children's Hospital, Little Rock

73104

Children's Hospital OU Medical Center, Oklahoma City

87131

University of New Mexico Health Sciences Center, Albuquerque

96826

Kapiolani Medical Center for Women and Children, Honolulu

03104

Dartmouth Hospital - Manchester, Manchester

05401

University of Vermont Medical Center, Burlington

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

IDeA States Pediatric Clinical Trials Network

NETWORK

NCT03686150 - Vitamin D Oral Replacement in Asthma | Biotech Hunter | Biotech Hunter